683 related articles for article (PubMed ID: 27181776)
1. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term cysteamine treatment in patients with cystinosis.
Ariceta G; Giordano V; Santos F
Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
[TBL] [Abstract][Full Text] [Related]
3. [Cystinosis : Diagnosis, cystine-depleting therapy, and transition].
Kaufeld J; Weber LT; Kurschat C; Canaan-Kuehl S; Brand E; Oh J; Pape L
Internist (Berl); 2018 Aug; 59(8):861-867. PubMed ID: 29671012
[TBL] [Abstract][Full Text] [Related]
4. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
Nesterova G; Williams C; Bernardini I; Gahl WA
Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
[TBL] [Abstract][Full Text] [Related]
5. Extrarenal complications of cystinosis.
Topaloglu R
Pediatr Nephrol; 2024 Aug; 39(8):2283-2292. PubMed ID: 38127152
[TBL] [Abstract][Full Text] [Related]
6. CTNS mRNA molecular analysis revealed a novel mutation in a child with infantile nephropathic cystinosis: a case report.
Papizh S; Serzhanova V; Filatova A; Skoblov M; Tabakov V; van den Heuvel L; Levtchenko E; Prikhodina L
BMC Nephrol; 2019 Oct; 20(1):400. PubMed ID: 31672123
[TBL] [Abstract][Full Text] [Related]
7. Nephropathic cystinosis: an update on genetic conditioning.
Topaloglu R
Pediatr Nephrol; 2021 Jun; 36(6):1347-1352. PubMed ID: 32564281
[TBL] [Abstract][Full Text] [Related]
8. Nephropathic Cystinosis Mimicking Bartter Syndrome: a Novel Mutation.
Bastug F; Nalcacioglu H; Ozaltin F; Korkmaz E; Yel S
Iran J Kidney Dis; 2018 Jan; 12(1):61-63. PubMed ID: 29421779
[TBL] [Abstract][Full Text] [Related]
9. [Cystinosis in adults: A systemic disease].
Servais A; Goizet C; Bertholet-Thomas A; Decramer S; Llanas B; Choukroun G; Novo R
Nephrol Ther; 2015 Jun; 11(3):152-9. PubMed ID: 25769364
[TBL] [Abstract][Full Text] [Related]
10. Cystinosis: a review.
Elmonem MA; Veys KR; Soliman NA; van Dyck M; van den Heuvel LP; Levtchenko E
Orphanet J Rare Dis; 2016 Apr; 11():47. PubMed ID: 27102039
[TBL] [Abstract][Full Text] [Related]
11. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
Brodin-Sartorius A; Tête MJ; Niaudet P; Antignac C; Guest G; Ottolenghi C; Charbit M; Moyse D; Legendre C; Lesavre P; Cochat P; Servais A
Kidney Int; 2012 Jan; 81(2):179-89. PubMed ID: 21900880
[TBL] [Abstract][Full Text] [Related]
12. Cystinosis: clinical presentation, pathogenesis and treatment.
Ivanova E; De Leo MG; De Matteis MA; Levtchenko E
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():176-84. PubMed ID: 25345100
[TBL] [Abstract][Full Text] [Related]
13. [Cystinosis: From the gene identification to the first gene therapy clinical trial].
Cherqui S
Med Sci (Paris); 2023 Mar; 39(3):253-261. PubMed ID: 36943122
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of cystinosis: mechanisms beyond cystine accumulation.
Wilmer MJ; Emma F; Levtchenko EN
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F905-16. PubMed ID: 20826575
[TBL] [Abstract][Full Text] [Related]
15. Follow-up and treatment of adults with cystinosis in the Netherlands.
Geelen JM; Monnens LA; Levtchenko EN
Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982
[TBL] [Abstract][Full Text] [Related]
16. Cystinosin-deficient rats recapitulate the phenotype of nephropathic cystinosis.
Hollywood JA; Kallingappa PK; Cheung PY; Martis RM; Sreebhavan S; 'Atiola RD; Chatterjee A; Buckels EJ; Matthews BG; Lewis PM; Davidson AJ
Am J Physiol Renal Physiol; 2022 Aug; 323(2):F156-F170. PubMed ID: 35695380
[TBL] [Abstract][Full Text] [Related]
17. An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis.
Emma F; Hoff WV; Hohenfellner K; Topaloglu R; Greco M; Ariceta G; Bettini C; Bockenhauer D; Veys K; Pape L; Hulton S; Collin S; Ozaltin F; Servais A; Deschênes G; Novo R; Bertholet-Thomas A; Oh J; Cornelissen E; Janssen M; Haffner D; Ravà L; Antignac C; Devuyst O; Niaudet P; Levtchenko E
Kidney Int; 2021 Nov; 100(5):1112-1123. PubMed ID: 34237326
[TBL] [Abstract][Full Text] [Related]
18. Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.
Ahlenstiel-Grunow T; Kanzelmeyer NK; Froede K; Kreuzer M; Drube J; Lerch C; Pape L
Pediatr Nephrol; 2017 Jan; 32(1):91-97. PubMed ID: 27350621
[TBL] [Abstract][Full Text] [Related]
19. Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis.
Hollywood JA; Przepiorski A; D'Souza RF; Sreebhavan S; Wolvetang EJ; Harrison PT; Davidson AJ; Holm TM
J Am Soc Nephrol; 2020 May; 31(5):962-982. PubMed ID: 32198276
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic Stem Cell Gene Therapy for Cystinosis: From Bench-to-Bedside.
Cherqui S
Cells; 2021 Nov; 10(12):. PubMed ID: 34943781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]